anti-Apolipoprotein A (APOA) Antibodies

The protein encoded by APOA is a serine proteinase that inhibits the activity of tissue-type plasminogen activator I. Additionally we are shipping Apolipoprotein A Kits (9) and Apolipoprotein A Proteins (3) and many more products for this protein.

list all antibodies Gene Name GeneID
APOA 4018
APOA  
How to order from antibodies-online
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Order online
  • orders@antibodies-online.com

Top anti-Apolipoprotein A Antibodies at antibodies-online.com

Showing 10 out of 48 products:

Catalog No. Reactivity Host Conjugate Application Images Quantity Delivery Price Details
Human Rabbit Un-conjugated WB WB Suggested Anti-LPA Antibody Titration: 0.2-1 ug/mlELISA Titer: 1:312500Positive Control: Jurkat cell lysate WB Suggested Anti-LPA  Antibody Titration: 0.2-1 µg/mL ELISA Titer: 1:.12500  Positive Control: Jurkat cell lysate 100 μL 2 to 3 Days
$289.00
Details
Human Rabbit Un-conjugated WB WB Suggested Anti-LPA Antibody Titration: 0.2-1 ug/mlELISA Titer: 1:312500Positive Control: Jurkat cell lysate WB Suggested Anti-LPA  Antibody Titration: 0.2-1 µg/mL ELISA Titer: 1:.12500  Positive Control: Jurkat cell lysate 100 μL 2 to 3 Days
$289.00
Details
Human Mouse Un-conjugated ICC, IHC, ELISA, WB Figure 1: Red: Control Antigen (100 ng), Purple: Antigen (10ng), Green: Antigen (50 ng), Blue: Antigen (100 ng) Figure 2: Immunofluorescence analysis of HepG2 cells using LPA mouse mAb (green) . Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin. 0.1 mg 3 to 4 Days
$430.10
Details
Human Mouse Un-conjugated ELISA, IF/ICC, IHC, WB 100 μg 11 to 16 Days
$469.05
Details
Human Mouse Un-conjugated EIA, IHC (p), WB 50 μL 6 to 8 Days
$495.00
Details
Human Goat Un-conjugated EIA, IHC (p) Human Liver (formalin-fixed, paraffin-embedded) stained with LPAfollowed by biotinylated anti-goat IgG secondary antibody, alkaline phosphatase-streptavidin and chromogen. 0.1 mg 11 to 13 Days
$768.40
Details
Human Mouse Un-conjugated IHC, ELISA, WB Figure 1: Immunohistochemical analysis of paraffin-embedded human Liver tissues using LPA mouse mAb Figure 2: Western blot analysis using LPA mouse mAb against truncated LPA-His recombinant protein (1) and truncated Trx-LPA (aa4330-4521) recombinant protein (2) . 100 μL 3 to 4 Days
$393.80
Details
Human Mouse Un-conjugated IHC, ELISA, WB Western blot analysis using LPA antibody against truncated LPA-His recombinant protein (1) and truncated Trx-LPA (aa4330-4521) recombinant protein (2). 100 μL 11 to 16 Days
$469.05
Details
Human Mouse Un-conjugated ELISA, IHC (p), WB   100 μL Available
$546.20
Details
Human Mouse Un-conjugated ELISA, IHC (p), WB Western blot analysis using LPA monoclonal antibody, clone 8F6A9  against truncated LPA-His recombinant protein (1) and truncated Trx-LPA(aa 4330-4521) recombinant protein (2). Immunohistochemical analysis of paraffin-embedded human liver tissues using LPA monoclonal antibody, clone 8F6A9 . 100 μL 11 to 12 Days
$374.67
Details

Top referenced anti-Apolipoprotein A Antibodies

  1. Human Monoclonal APOA Primary Antibody for IHC, ELISA - ABIN966490 : : USA: bringing reality to the great American tobacco show. in Tobacco control 2007 (PubMed)
    Show all 2 Pubmed References

  2. Human Monoclonal APOA Primary Antibody for IHC, ELISA - ABIN969261 : Ranga, Kalra, Tandon, Gambhir, Mehrotra: Effect of aspirin on lipoprotein(a) in patients with ischemic stroke. in Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2007 (PubMed)
    Show all 2 Pubmed References

  3. Human Monoclonal APOA Primary Antibody for ICC, IHC - ABIN969533 : Nicholls, Tang, Scoffone, Brennan, Hartiala, Allayee, Hazen: Lipoprotein(a) levels and long-term cardiovascular risk in the contemporary era of statin therapy. in Journal of lipid research 2010 (PubMed)
    Show all 2 Pubmed References

More Antibodies against Apolipoprotein A Interaction Partners

Human Apolipoprotein A (APOA) interaction partners

  1. Stable outpatients with symptomatic artery disease and Lp(a) levels >30mg/dL were at a 5-fold higher risk for subsequent myocardial infarction, stroke or limb amputation. Those with levels >50mg/dL were at an over 10-fold higher risk.

  2. In patients with potential familial hypercholesterolemia, positive correlations between concentrations of Lp(a) and PCSK9, as well as of Lp(a)-PCSK9 plasma complex with large subfractions of intermediate and low-density lipoproteins (IDL-1 and LDL-C), were determined by the low molecular weight apo(a) phenotype.

  3. Lp(a) concentration, but not apo(a) isoform size, is independently associated with angiographic extent and severity of coronary artery disease, but not carotid artery plaque.

  4. potential role for Lp(a) as a possible risk marker useful to stratify, among bicuspid aortic valve stenosis patients

  5. Lp(a) molar/mass ratios are threshold, method, and isoform dependent

  6. Meta-analysis: Genetic variations at the LPA locus are associated with CHD events during statin therapy independently of the extent of low-density lipoprotein cholesterol lowering.

  7. Lp(a) accelerates progression of atherosclerosis in these individuals, thereby contributing to their increased ASCVD risk

  8. Proinflammatory interleukin 1 (IL-1(+)) genotypes modulate the risk of Lp(a) long-term cardiovascular disease (CVD) events and coronary artery disease (CAD).

  9. The autors results confirm the association between LPA SNPs rs10455872 and rs3798220 with AS and demonstrated that individuals with 2 risk alleles have a 2-fold or greater odds of developing AS.

  10. The LPA 9p21 locus was associated with risk of aortic valve stenosis.

  11. High lipoprotein(a) levels were associated with a higher incidence of major adverse limb events after endovascular treatment for patients with aortoiliac lesions.

  12. In a multiethnic sample, Lp(a)-related risks of heart failure were only evident in white participants.

  13. High plasma lipoprotein a levels accelerated the progression of atherosclerosis in end-stage renal disease through lipoprotein a accumulation in the arteries.

  14. The population differences in Lp(a) concentrations between Finnish and Central European populations originate not only from a different LPA isoform distribution but suggest the existence of novel functional variation in the small-isoform range.

  15. Elevated lipoprotein(a) concentrations were independently associated with an increased risk of abdominal aortic aneurysms.

  16. Lp(a) seems to be an independent risk factor for acute coronary syndromes in individuals <45 years, and high Lp(a) levels increase by approximately 3folds the risk for ACS. The association is preserved but is less in middle-aged individuals (45-60 years) and is abolished >60 years.

  17. Common p2y13 polymorphisms are associated with plasma inhibitory factor 1 and lipoprotein(a) concentrations, heart rate and body fat mass and may modulate cardiovascular risk.

  18. Elevated Lp(a) levels were independently associated with the presence and severity of coronary artery disease in patients with type 2 diabetes.

  19. pplication of system Lipoprint (Quantimetrix USA) provides no opportunity to unequivocally interpret data concerning input of sub-fractions of lipoproteins into risk of development of cardio-vascular diseases in patients with pathological lipid profile and higher concentration of lipoprotein (a).

  20. Elevated Lp(a) levels were independent predictors of increases in carotid atherosclerosis burden.

Apolipoprotein A (APOA) Antigen Profile

Protein Summary

The protein encoded by this gene is a serine proteinase that inhibits the activity of tissue-type plasminogen activator I. The encoded protein constitutes a substantial portion of lipoprotein(a) and is proteolytically cleaved, resulting in fragments that attach to atherosclerotic lesions and promote thrombogenesis. Elevated plasma levels of this protein are linked to atherosclerosis. Depending on the individual, the encoded protein contains 2-43 copies of kringle-type domains. The allele represented here contains 15 copies of the kringle-type repeats and corresponds to that found in the reference genome sequence.

Gene names and symbols associated with anti-Apolipoprotein A (APOA) Antibodies

  • lipoprotein(a) (LPA) antibody
  • AK38 antibody
  • Apo(a) antibody
  • APOA antibody
  • LP antibody
  • Lp(a) antibody

Protein level used designations for anti-Apolipoprotein A (APOA) Antibodies

antiangiogenic AK38 protein , apo(a) , apolipoprotein(a) , lp(a)

GENE ID SPECIES
4018 Homo sapiens
709528 Macaca mulatta
Selected quality suppliers for anti-Apolipoprotein A (APOA) Antibodies
Did you look for something else?